168 related articles for article (PubMed ID: 28791387)
1. Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route.
Meryet-Figuière M; Lecerf C; Varin E; Coll JL; Louis MH; Dutoit S; Giffard F; Blanc-Fournier C; Hedir S; Vigneron N; Brotin E; Pelletier L; Josserand V; Denoyelle C; Poulain L
Oncol Rep; 2017 Oct; 38(4):1949-1958. PubMed ID: 28791387
[TBL] [Abstract][Full Text] [Related]
2. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
Mu P; Nagahara S; Makita N; Tarumi Y; Kadomatsu K; Takei Y
Int J Cancer; 2009 Dec; 125(12):2978-90. PubMed ID: 19422046
[TBL] [Abstract][Full Text] [Related]
3. Atelocollagen-mediated intravenous siRNA delivery specific to tumor tissues orthotopically xenografted in prostates of nude mice and its anticancer effects.
Yuan Y; Makita N; Cao D; Mihara K; Kadomatsu K; Takei Y
Nucleic Acid Ther; 2015 Apr; 25(2):85-94. PubMed ID: 25692652
[TBL] [Abstract][Full Text] [Related]
4. Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
Simonin K; N'Diaye M; Lheureux S; Loussouarn C; Dutoit S; Briand M; Giffard F; Brotin E; Blanc-Fournier C; Poulain L
Apoptosis; 2013 Apr; 18(4):492-508. PubMed ID: 23344663
[TBL] [Abstract][Full Text] [Related]
5. Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis.
Brotin E; Meryet-Figuière M; Simonin K; Duval RE; Villedieu M; Leroy-Dudal J; Saison-Behmoaras E; Gauduchon P; Denoyelle C; Poulain L
Int J Cancer; 2010 Feb; 126(4):885-95. PubMed ID: 19634140
[TBL] [Abstract][Full Text] [Related]
6. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.
Minakuchi Y; Takeshita F; Kosaka N; Sasaki H; Yamamoto Y; Kouno M; Honma K; Nagahara S; Hanai K; Sano A; Kato T; Terada M; Ochiya T
Nucleic Acids Res; 2004 Jul; 32(13):e109. PubMed ID: 15272050
[TBL] [Abstract][Full Text] [Related]
7. Calcium signals inhibition sensitizes ovarian carcinoma cells to anti-Bcl-xL strategies through Mcl-1 down-regulation.
Bonnefond ML; Lambert B; Giffard F; Abeilard E; Brotin E; Louis MH; Gueye MS; Gauduchon P; Poulain L; N'Diaye M
Apoptosis; 2015 Apr; 20(4):535-50. PubMed ID: 25627260
[TBL] [Abstract][Full Text] [Related]
8. Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer.
Kawata E; Ashihara E; Kimura S; Takenaka K; Sato K; Tanaka R; Yokota A; Kamitsuji Y; Takeuchi M; Kuroda J; Tanaka F; Yoshikawa T; Maekawa T
Mol Cancer Ther; 2008 Sep; 7(9):2904-12. PubMed ID: 18790771
[TBL] [Abstract][Full Text] [Related]
9. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.
Takeshita F; Minakuchi Y; Nagahara S; Honma K; Sasaki H; Hirai K; Teratani T; Namatame N; Yamamoto Y; Hanai K; Kato T; Sano A; Ochiya T
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12177-82. PubMed ID: 16091473
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
[TBL] [Abstract][Full Text] [Related]
12. Application of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes for gene transfer into human ovarian carcinoma cells.
Verbaan FJ; Klein Klouwenberg P; van Steenis JH; Snel CJ; Boerman O; Hennink WE; Storm G
Int J Pharm; 2005 Nov; 304(1-2):185-92. PubMed ID: 16129577
[TBL] [Abstract][Full Text] [Related]
13. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
14. siRNA-Based Drug Targeting Human Bcl-xL Against Cancers.
Takei Y
Methods Mol Biol; 2019; 1974():31-40. PubMed ID: 31098993
[TBL] [Abstract][Full Text] [Related]
15. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
16. Lipoic acid decreases Mcl-1, Bcl-xL and up regulates Bim on ovarian carcinoma cells leading to cell death.
Kafara P; Icard P; Guillamin M; Schwartz L; Lincet H
J Ovarian Res; 2015 Jun; 8():36. PubMed ID: 26063499
[TBL] [Abstract][Full Text] [Related]
17. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics.
Takei Y; Kadomatsu K; Yuzawa Y; Matsuo S; Muramatsu T
Cancer Res; 2004 May; 64(10):3365-70. PubMed ID: 15150085
[TBL] [Abstract][Full Text] [Related]
18. Cafestol overcomes ABT-737 resistance in Mcl-1-overexpressed renal carcinoma Caki cells through downregulation of Mcl-1 expression and upregulation of Bim expression.
Woo SM; Min KJ; Seo BR; Nam JO; Choi KS; Yoo YH; Kwon TK
Cell Death Dis; 2014 Nov; 5(11):e1514. PubMed ID: 25375379
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.
Landen CN; Chavez-Reyes A; Bucana C; Schmandt R; Deavers MT; Lopez-Berestein G; Sood AK
Cancer Res; 2005 Aug; 65(15):6910-8. PubMed ID: 16061675
[TBL] [Abstract][Full Text] [Related]
20. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.
Urban-Klein B; Werth S; Abuharbeid S; Czubayko F; Aigner A
Gene Ther; 2005 Mar; 12(5):461-6. PubMed ID: 15616603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
